Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis of promiscuous substrate transport by Organic Cation Transporter 1. | Nat Commun | 2023 | 37821493 | PubTator, text mining | PubMed |
| Artificial intelligence-based prediction of molecular and genetic markers for hepatitis C-related hepatocellular carcinoma. | Ann Med Surg (Lond) | 2023 | 37811067 | PubTator, text mining | PubMed |
| The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug-Drug Interaction in Healthy Participants. | Eur J Drug Metab Pharmacokinet | 2023 | 37804430 | PubTator, text mining | PubMed |
| Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation. | Ther Adv Endocrinol Metab | 2023 | 37780174 | PubTator, text mining | PubMed |
| GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors. | Am J Psychiatry | 2023 | 37777856 | PubTator, text mining | PubMed |
| EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma. | Viruses | 2023 | 37766321 | PubTator, text mining | PubMed |
| Interaction of ALK Inhibitors with Polyspecific Organic Cation Transporters and the Impact of Substrate-Dependent Inhibition on the Prediction of Drug-Drug Interactions. | Pharmaceutics | 2023 | 37765282 | PubTator, text mining | PubMed |
| Niraparib and Advanced Ovarian Cancer: A Beacon in the Non-BRCA Mutated Setting. | Pharmaceuticals (Basel) | 2023 | 37765068 | PubTator, text mining | PubMed |
| Bisindolyl Maleimides and Indolylmaleimide Derivatives-A Review of Their Synthesis and Bioactivity. | Pharmaceuticals (Basel) | 2023 | 37764999 | PubTator, text mining | PubMed |
| Clinical Outcomes of Patients with Chronic Myeloid Leukemia and COVID-19 Infection-A Single Center Survey. | Medicina (Kaunas) | 2023 | 37763683 | PubTator, text mining | PubMed |
| Insights into Repeated Renal Injury Using RNA-Seq with Two New RPTEC Cell Lines. | Int J Mol Sci | 2023 | 37762531 | PubTator, text mining | PubMed |
| Regulation of Transporters for Organic Cations by High Glucose. | Int J Mol Sci | 2023 | 37762353 | PubTator, text mining | PubMed |
| Integrated analysis of SKA1-related ceRNA network and SKA1 immunoassays in HCC: A study based on bioinformatic. | Medicine (Baltimore) | 2023 | 37746945 | PubTator, text mining | PubMed |
| Advances in the Management of Diabetes Mellitus: A Focus on Personalized Medicine. | Cureus | 2023 | 37724233 | PubTator, text mining | PubMed |
| Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitors. | Biochem Pharmacol | 2023 | 37722628 | PubTator, text mining | PubMed |
| Imeglimin: A Clinical Pharmacology Review. | Clin Pharmacokinet | 2023 | 37713097 | PubTator, text mining | PubMed |
| Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib. | Blood Cancer J | 2023 | 37696829 | PubTator, text mining | PubMed |
| Genetic polymorphisms are associated with individual susceptibility to dexmedetomidine. | Front Genet | 2023 | 37693312 | PubTator, text mining | PubMed |
| Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome. | Cells | 2023 | 37681921 | PubTator, text mining | PubMed |
| OCT1-dependent uptake of structurally diverse pyrrolizidine alkaloids in human liver cells is crucial for their genotoxic and cytotoxic effects. | Arch Toxicol | 2023 | 37676300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=12